Abbott Laboratories (NYSE:ABT) Given New $127.00 Price Target at Morgan Stanley
Abbott Laboratories (NYSE:ABT – Get Free Report) had its price objective upped by equities research analysts at Morgan Stanley from $117.00 to $127.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has an “equal weight” rating on the healthcare product maker’s stock. Morgan Stanley’s price target indicates a potential downside of […]
Abbott Laboratories (NYSE:ABT – Get Free Report) had its price objective upped by equities research analysts at Morgan Stanley from $117.00 to $127.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has an “equal weight” rating on the healthcare product maker’s stock. Morgan Stanley’s price target indicates a potential downside of […]
